Primer Mesane Karsinomunun Karaciğer Metastazı: Olgu Sunumu
Öz
Anahtar Kelimeler
References
- 1 Aydın S. Türkiye’de üriner sistem kanserlerin görülme sıklığı. Turkish Journal of Urology. 2007; 33: 392-7.
- 2 Black, P.C., G.A. Brown, and C.P. Dinney, The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol. 2009; 27(1): 3-7.
- 3 Messing EM. Urothelial tumors of the bladder. Campbell’s urology Philadelphia. 2007; 2407-47.
- 4 Burger, M., Catto, J. W., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., et al., Epidemiology and risk factors of urothelial bladder cancer. European urology. 2013; 63(2): 234-41.
- 5 DeGeorge, K.C., H.R. Holt, and S.C. Hodges, Bladder Cancer: Diagnosis and Treatment. Am Fam Physician. 2017; 96(8): 507-14.
- 6 Bajorin, D. F., Dodd, P. M., Mazumdar, M., Fazzari, M., McCaffrey, J. A., Scher, H. I., et al., Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. Journal of Clinical Oncology. 1999; 17(10): 3173-81.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Case Report
Authors
Uğur Ergün
*
0000-0002-6111-0030
Türkiye
Publication Date
October 25, 2022
Submission Date
April 13, 2022
Acceptance Date
August 29, 2022
Published in Issue
Year 2022 Volume: 3 Number: 2